Boston, USA. April 4th 2025 – GA International, a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its DYMO® LabelWriter 5-Series Printing Kits are now compatible with eLabNext’s Digital Lab Platform (DLP) — an intuitive and flexible system for collecting, managing, and analyzing laboratory information. 

“We’re excited to expand our partnership with eLabNext by introducing this Dymo® LabelWriter 550 Add-On,” comments George Ambartsoumian, Founder and CEO of GA International. “This tool allows researchers to print labels directly from the eLabNext interface, making sample identification faster, easier, and more reliable. It’s another step forward in our shared mission to streamline lab workflows and improve sample and data management in laboratories.” 

The integration is available in the eLabMarketplace through an Add-on, and provides researchers with a reliable, precise, and user-friendly solution for labeling in critical laboratory workflows. Allowing users access to pre-designed label templates, ensuring perfect formatting, dimensions, and layout alignment directly within the eLabNext DLP. 

“We jump on every opportunity to enhance our platform by integrating tools that simplify workflows, collaborating with companies that share our passion for sample and data management, and streamlining lab operations for our users,” says Zareh Zurabyan, VP of Commercial, Americas. “This recent collaboration with LabTAG is a win for everyone and ensures that labs can focus on their research with confidence, knowing their labeling needs are met with innovative and reliable technology.” 

The new add-on aims to streamline laboratory labeling by combining the Dymo® LabelWriter5-Series (550, 550 Turbo, and 5XL) with LabTAG’s durable cryogenic labels, offering a cost-effective labeling solution, particularly beneficial for labs working on a tight budget.

To learn more about eLabNext’s DLP and how to connect with LabTAG’s Dymo® LabelWriter 550 Printer Add-on, visit the eLabMarketplace.

ENDS

NOTTINGHAM, UK. 3rd April, 2025 – 4D Biomaterials Ltd, the materials manufacturing subsidiary of 4D Medicine Ltd, a UK university spin-out company developing next-generation bioresorbable medical devices, today announced it has achieved ISO 13485:2016 certification from The British Standards Institution (BSI). 

This globally recognised quality standard for medical device manufacturing marks a critical milestone in the company’s path to market, demonstrating high quality, low risk and customer-focused manufacturing capability. 

The certification confirms that 4D Biomaterials Ltd operates under a quality management system that meets stringent international regulatory requirements — a core prerequisite for the raw materials used in medical devices seeking regulatory approvals, clinical deployment, and global distribution. As such, certification significantly de-risks the company’s commercial strategy. 

Phil Smith, CEO of parent company, 4D Medicine Ltd commented:

“This achievement is a pivotal moment for our materials manufacturing business. ISO 13485 certification validates its operational systems and sends a clear signal to partners and investors: we are ready to scale. It also reflects the maturity of our technology platform, the discipline of our team, and our commitment to executing a high-quality commercialisation strategy.”

This milestone positions 4D to accelerate the development of commercial partnerships, regulatory approvals, and revenue-generating opportunities as it advances its differentiated product pipeline toward global markets.

ENDS

NOTTINGHAM, UK. March 11th, 2025 – 4D Medicine Ltd, an emerging innovator in the biomaterials and medical device sector, is proud to announce the launch of its newly redesigned corporate website, www.4dmedicine.co.uk.

The site is designed to offer a comprehensive resource for investors, strategic partners, and healthcare professionals, highlighting the company’s groundbreaking 4Degra® bioabsorbable polymer technology and its potential to transform the medical device industry.

The new website offers information on the unique properties of 4Degra®, a next-generation bioabsorbable polymer developed to improve patient outcomes in medical device applications. 4Degra®’s unparalleled versatility and biocompatibility make it an ideal material for a wide range of devices, including those used in musculoskeletal repair, soft tissue regeneration and drug-delivery.

“4Degra® represents the next evolution in bioabsorbable materials, and this website serves as an essential tool to communicate the exciting opportunities that lie ahead for investors and collaborators,” said Phil Smith, CEO of 4D Medicine. 

“We’ve designed the site to not only inform but to also demonstrate the potential impact our technology can have in improving surgical outcomes and improving lives.”

Key features of the new website include:

The launch of this website underscores 4D Medicine’s commitment to transparency, collaboration, and ongoing innovation. The company is poised to lead the way in delivering solutions that enhance patient care and create lasting value for its partners and stakeholders.

ENDS

BOSTON, MA. March 5th, 2025 – Today, protocols.io, a platform that enables academic and industry researchers to record and share up-to-date methods for research, announced that, under eLabNext leadership, its platform is now available for integration with eLabNext’s Digital Lab Platform (DLP), an intuitive and flexible system for collecting, managing, and analyzing laboratory information. 

The seamless connections between protocols.io and the DLP enable users to better understand what protocol was used, by whom, on which samples, and when. This comprehensive digital documentation and trackability help ensure experimental reproducibility in the scientific research fields.

“Scientific research faces challenges with experimental reproducibility, and having tools to combat them is a top priority,” said Zareh Zurabyan, Head of eLabNext, Americas. 

“Integrating the protocols.io platform with our Digital Lab Platform puts reproducible protocols at each user’s fingertips, allowing researchers to conduct more reproducible and trustworthy science. We are excited to further this goal with the protocols.io team.”

With the integration of the protocols.io add-on, eLabNext users can access comprehensive, step-by-step protocols directly from their protocols.io account. In addition, the integration allows users to search a library of private and public protocols, which can be easily imported into their DLP.

“From our first meeting with eLabNext to discuss integration options, it was clear that we share the same mission and approach to serving the research community,” explains Lenny Teytelman, Founder and President at protocols.io. 

“As we strive to encourage and support collaboration among researchers, it is essential that the tool makers collaborate as well. Working with the eLabNext team is a pleasure!” 

To learn more about eLabNext’s DLP and how to connect with the protocols.io add-on, visit the eLabMarketplace.

ENDS

BOSTON, MA. February 24th, 2025 – Elemental Machines and eLabNext announced today that the Elemental Machines’ Connector add-on will now be available for free in the eLabMarketplace, eLabNext’s application library for extending and personalizing the functionality of their Digital Lab Platform. The Elemental Machines’ Connector supports wireless Elemental Machine sensors, which can monitor and record real-time data on temperature, humidity, and other environmental factors, allowing labs to respond instantly to temperature deviations among storage devices with customizable cellular alerts. 

“We are proud to continue partnering with eLabNext and serving customers worldwide,” says Ed Seguine, CEO of Elemental Machines. “With the launch of our new Elemental Machines’ Connector add-on, we’re showcasing our long-term vision and commitment to this partnership. This release not only supports our existing customers but offers new customers the chance to experience the value of the integration. By merging insights from Elemental Machines with eLabNext, users can gain a deeper, more sophisticated understanding of samples before and during scientific processes.”

The integration also gives users full visibility into equipment status and sample storage, driving informed decision-making, better resource management, greater reproducibility and compliance, and enhanced lab workflows. The Elemental Machines’ Connector automatically captures, documents, and provides access to data through cellular networks on a variety of environmental factors for audits and reviews to improve experimental accuracy.

“Centralizing lab data is one of the core missions of our Digital Lab Platform,” explains Zareh Zurabyan, Head of eLabNext, Americas. “The Elemental Machines’ Connector opens up eLabNext software to collect environmental data generated by lab equipment, giving users easy access to all temperature readings, including the duration and magnitude of deviations. Whether you are doing clinical work, R&D, diagnostics, or long-term biobanking, it is important to have insight into sample integrity, which generates terabytes of data using a range of equipment. This integration allows users to collect historical data on temperature deviations across the entire sample journey through the lab, giving them more confidence in their sample data.”

The Element-T sensors are capable of continuously monitoring and transmitting temperature data from freezers, refrigerators, and lab spaces. Download the Elemental Machines’ Connector for eLabNext from the eLabMarketplace and start integrating real-time data into your lab operations today.

BOSTON, MA. January 30th, 2025 — In a groundbreaking move set to transform the way scientific research is captured and managed, Boston-based SciShield, and Groningen, Netherlands-based eLabNext, have merged to launch the world’s first and only Scientific Management Platform (SMP). The combined company has been re-branded as SciSure. Founded by scientists for scientists, SciSure delivers the unique combination of eLabNext’s Digital Lab Platform with its ELN (Electronic Laboratory Notebook) and LIMS (Laboratory Information Management System) and SciShield’s comprehensive, trusted, and compliant EHS (Environmental Health & Safety) platform. The SMP will address the most pressing issues in science today: fragmented systems and the inefficiencies they create.  
 
“Scientific organizations face the costly challenge of maintaining disparate systems that burden scientists and add unnecessary cost, complexity, and risk. Today, that changes,” said Phil Meer, Chief Executive Officer. “By bringing eLabNext and SciShield together, we accelerate our vision to deliver an unparalleled scientist experience via a platform that will serve as a digital ecosystem for stakeholders vested in ensuring accurate, safe, compliant, and streamlined scientific research.”

Unparalleled Global Scale

Trust, protection, and research integrity form the core values of SciSure. The combined company offers unparalleled global scale, featuring 800+ unique customer organizations, 550,000+ research and administrative users, and 37,000+ lab groups across Europe, North America, Asia, and Australia. Customers include global Fortune 100 Biopharma organizations, over one-third of United States R1 Academic Institutions, and laboratories within companies across diverse industries, including healthcare, oil & gas, and food safety.
 
Research, Safety, Training, and Operations in a Single Platform

For decades, scientists, Lab Operations, Facilities Management, and EHS professionals have managed the dynamic and complex operational and regulatory requirements that span scientific organizations using fragmented technologies. These disconnected systems aren’t just inconvenient—they create significant risks. These risks include inadequate research documentation, poor IP management, loss of critical experiment data, lapses in training, compliance violations, and the mishandling of hazardous materials. The SMP mitigates these risks by creating synchronized, intelligent, and proactive data-driven insights and seamless, secure workflows to enable scientists to effectively conduct and document their research, and scientific organizations to proactively inspect, report, remediate, and, ultimately, minimize risk. Moreover, via its partner-enabled Marketplace, SciSure offers an open digital ecosystem designed for internal customer systems and third-party software vendors to seamlessly deliver third-party data and workflows into and out of the Scientific Management Platform (SMP).

“Our mission is to support scientific organizations in facilitating unburdened, uncompromised, and safe scientific advancement,” said Nathan Watson, SciShield Founder and SciSure Chief Strategy Officer. “The SMP enables fast, efficient, and more reliable decision-making, allowing scientists to focus on what they do best: advancing their scientific discoveries.”
 
A Solution Designed by Scientists, for Scientists

With scientists and researchers at the core of SciSure’s Senior Leadership Team, the Scientific Management Platform (SMP) will improve the scientist experience, with benefits including:
 
– Liberating scientists from administrative and compliance burdens
– Enhancing trust in digital solutions and accuracy of data
– Establishing a home base for planning, documenting, and organizing research data
– Streamlining and organizing multiple technologies, allowing for data from adjacent systems to be securely integrated and available to scientists within their daily workflow
 
“Scientists must have confidence and trust in the digital solutions they use. When trust goes up, speed and innovation follow,” said Erwin Seinen, eLabNext co-founder and SciSure Chief Revenue Officer. “The SMP is the ultimate home base for scientists, lab operations, and EHS professionals to thrive together,” added Wouter de Jong, eLabNext co-founder and SciSure Chief Product Officer.

Ownership

SciSure is backed by Strattam Capital. Strattam Capital first invested in SciShield in 2023 to enable the company to accelerate its pace of innovation while continuing to provide best-in-class services to its high-profile customer base. In addition, the investment provided SciShield with resources to expand its product offerings, operations, and sales teams.
 
About the SMP

The Scientific Management Platform (SMP) redefines laboratory efficiency and compliance, empowering organizations to deliver on their missions without compromise. By uniting critical systems, the SMP champions a new era of trust and innovation in digital science, fostering collaboration and liberating scientists and researchers to make the breakthroughs the world is counting on them to make.

Explore more about the SciSure vision and learn how we’re reimagining the Scientist Experience at www.scisure.com.
 
For more information, please contact:
Jon Zibell
Vice President of Global Alliances & Marketing
Jon.Zibell@scisure.com

NOTTINGHAM, UK. January 28th, 2025 – Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham, UK.

The new facility is in addition to its existing 50,000 sq. ft facility, Trent Gateway, and the purpose-built facility has been designed specifically in line with the revised EU GMP Annex-1 regulations. The 7,000 sq. ft facility will support the manufacturing of aseptic and terminally sterilised small volume liquids and powders for parenteral, nasal and pulmonary delivery.

The new facility has the capability to support formulation development, clinical manufacture and analytical testing, with batch sizes of up to 2,000 vials, pre-filled syringes and pre-filled cartridges for liquid formulations and pre-sterilized powders.

The expansion is a natural progression for Upperton which already develops and manufactures small molecule and biological, non-sterile, oral, nasal and pulmonary dosage forms from early development to late-stage clinical manufacture for global biotech and pharmaceutical companies. 

Nikki Whitfield, Chief Executive Officer at Upperton, said: “We are delighted to complete the build of our sterile facility. The combined experience of our leadership team in sterile facility builds and subsequent operations ensures that we are ideally placed as a CDMO partner of choice for small to mid-sized biotech and pharma looking to get into the clinic quickly with fast access to sterile manufacturing services.”

The sterile facility will feature two cleanrooms with advanced VHP isolation technology and carry out GMP manufacturing of sterile drug products making use of existing full-service formulation development and quality control laboratories.

Jon Austwick, Director of Quality and Compliance at Upperton, said: “This expansion illustrates our continued investment in our capabilities to support drug developers to scale and accelerate the path to delivering safe and effective medicines to patients. The facility has been built with the highest level of quality and is a testament to our internal teams and build vendor who have worked tirelessly over the past 12 months to bring our vision to life.” 

This investment in sterile drug product manufacturing enhances the existing service offering from Upperton, which provides formulation development across a broad range of dosage forms, clinical trial supply, and late-stage manufacturing for non-sterile dosage forms for both small molecules and biologics.

Whilst the commissioning of the facility, along with the installation and validation of new equipment continues, Upperton will utilise existing expertise within its research and development and analytical teams to support the pre-formulation and stability studies for early proof-of-concept products for parenteral, nasal and pulmonary delivery. 

ENDS

FRAMINGHAM, MA. December 10th, 2024 – Today, eLabNext announced that its customizable Digital Laboratory Platform can integrate with SPT Labtech’s compact, user-friendly barcode reader, BioMicroLab Scan. The free add-on can be accessed through the eLabMarketplace, eLabNext’s application library for extending and personalizing platform functionality, enabling users to rapidly scan and decode the broadest range of tube racks on the market, including cryotubes, cryovials, cryoboxes, glass vials, and ANSI/SLAS microplate standard labware. 

By adding the BioMicroLab Scan application to eLabNext’s platform, users can work with confidence, knowing that sample identification, even for extensive sample libraries, is taken care of. The connection between the BioMicroLab Scan and eLabNext also gives users a quick and easy way of storing integral sample data in the platform. Automatic transfer of information ensures research integrity and data integrity so scientists can focus more time and effort on other tasks.

“The integration of the BioMicroLab Scan with eLabNext will bring seamless data tracking to more labs,” says Cory Tiller, Product Manager for Sample Management at SPT Labtech. “The combination of eLabNext’s approachable platform and the Scan’s flexibility means that any lab with 2D barcoded tubes can go from sample creation to inventory update in moments.”

“Today’s labs require seamless automation and integrations, so we’re always on the lookout for any tool that helps our users circumvent issues with sample management and tracking,” comments Zareh Zurabyan, Head of eLabNext, Americas. “By allowing users to integrate the BioMicroLab Scan with our platform, they can secure their samples with one of the most versatile laboratory barcode readers on the market, and scale their lab operations efficiently.”

The BioMicroLab Scan can capture and decode SBS format racks in less than 1 second and 81/100/196 cryobox formats in less than 2 seconds. It also features compatibility with cold environments, which is essential for any laboratory personnel in the life science industry and users of the eLabNext platform. 

FRAMINGHAM, MA. December 9th, 2024 – Nikon and eLabNext partner to enhance data integration between NIS-Elements imaging software and eLabNext’s Digital Lab Platform.

The NIS-Elements eLabNext module allows users to seamlessly exchange experimental details between NIS-Elements and eLabNext’s Digital Lab Platform with high efficiency and minimal effort. This integration enables a comprehensive record of all data while reducing potential duplication and entry errors. Furthermore, it allows for easier replication of experimental protocols and allows the reuse of information for similar experiments.

 

“This partnership marks an exciting milestone for our company and the scientific community at large,” says Zareh Zurabyan, Head of eLabNext, Americas. “This innovative integration will impact day-to-day operations in the lab and provide unparalleled value to our customers. For the first time ever a complicated experiment workflow that is dependent on many sources of data can now be centralized and made more efficient with this Module, ultimately enhancing customer experience, boosting collaboration, and unlocking new features. Most importantly, this integration will help labs to scale up their operations in a compliant and secure environment which will help them to get to their breakthroughs much faster!”

 

“Nikon is excited to introduce this progressive integration to seamlessly synchronize experimental data with an electronic lab notebook” said Richard Gruskin, Senior General Manager, Software Systems. “This functionality augments the existing capabilities offered by NIS-Elements and offers a true digital experience by streamlining the exchange of experiment metadata and quantitative results while increasing productivity and experimental repeatability.”

Main Features*

• Upload experimental details and imaging conditions. Comprehensive experimental metadata, such as the complete list of microscope and peripheral hardware settings and any operator-defined custom metadata, can be uploaded from NIS-Elements directly into tables or as attachments to their own sections in the designated eLabJournal Experiment.

• Upload image thumbnails. Selected image thumbnails from the acquired microscope experiment data can be uploaded to eLabNext.

• Compatible with NIS-Elements JOBs and General Analysis (GA3) modules. The experiment acquisition and analysis protocols, analysis results and associated image data can automatically be uploaded from NIS-Elements to eLabNext.

• Ability to download experiment protocol directly into image metadata. Experimental protocols documented in selected eLabNext Experiment sections can be downloaded and saved directly in NIS-Elements’ ND2 image file format.

 

BOSTON, MA. November 11th, 2024 – The Design, Automation, Manufacturing, and Processes (DAMP) Lab and eLabNext announced a formal partnership today to coincide with the kick-off of the International Workshop for BioManufacturing Automation 2024 at Boston University (BU). The cooperative plan will focus on building an ordering platform for the DAMP lab’s suite of molecular biology services, which will be called DAMP Lab Canvas, and integrating it with the eLabNext Digital Lab Platform (DLP). 

 

“This initiative could provide an open-ecosystem software to biotech companies and the entire science community that could streamline their manufacturing and discovery processes,” explains Professor Douglas Densmore, PhD, Director of the DAMP Lab. “We chose to collaborate with eLabNext because the platform is so easy to use and the positive, supportive relationship we’ve developed over years of working alongside one another.”

 

For the past few years, the DAMP Lab and eLabNext have worked together, most notably during the COVID-19 pandemic, to process 2.4 million COVID-19 tests between 2020 and 2022 to limit the spread of the virus across the BU campus. The eLabNext DLP was integral in this effort, acting as a robust ELN & LIMS for protocol storage, inventory management, and sample tracking. 

 

“This collaboration is rooted in an alignment on several foundational values, all to encourage innovation in the scientific community,” says Zareh Zurabyan, Head of eLabNext, Americas. “Creating the tools for any organization to build an ecosystem that connects all of their digital needs to optimize their physical lab operations is a win for everyone. On a more granular level, this collaboration simplifies the ordering process, connects customers directly with vendors, and facilitates the transfer of protocols and other information between eLabNext and other laboratory systems. Together, we hope to garner more engagement in automated LIMS management and ease the burden of order placement with the DAMP Lab.”